Evidence map›Paper›PMID 26763232›Full record

ArticleThe Journal of biological chemistry2016

Docosahexaenoic Acid Promotes Axon Outgrowth by Translational Regulation of Tau and Collapsin Response Mediator Protein 2 Expression.

Toshinari Mita, Taira Mayanagi, Hiroshi Ichijo, Kentaro Fukumoto, Kotaro Otsuka, Akio Sakai, Kenji Sobue

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Mice Deficient inMolecular and cellular biology · 2017
    Article
  13. Review
  14. The DPYSL2 gene connects mTOR and schizophrenia.Translational psychiatry · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Toshinari MitaFrom the Department of Neuroscience, Institute of Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan and the Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Morioka 020-8505, Japan.
Taira MayanagiFrom the Department of Neuroscience, Institute of Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan and.
Hiroshi IchijoFrom the Department of Neuroscience, Institute of Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan and.
Kentaro FukumotoFrom the Department of Neuroscience, Institute of Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan and the Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Morioka 020-8505, Japan.
Kotaro Otsukathe Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Morioka 020-8505, Japan.
Akio Sakaithe Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Morioka 020-8505, Japan.
Kenji SobueFrom the Department of Neuroscience, Institute of Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan and ksobue@iwate-med.ac.jp.
Iwate Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

n-3 PUFAs are essential for neuronal development and brain function. However, the molecular mechanisms underlying their biological effects remain unclear. Here we examined the mechanistic action of docosahexaenoic acid (DHA), the most abundant n-3 polyunsaturated fatty acids in the brain. We found that DHA treatment of cortical neurons resulted in enhanced axon outgrowth that was due to increased axon elongation rates. DHA-mediated axon outgrowth was accompanied by the translational up-regulation of Tau and collapsin response mediator protein 2 (CRMP2), two important axon-related proteins, and the activation of Akt and p70 S6 kinase. Consistent with these findings, rapamycin, a potent inhibitor of mammalian target of rapamycin (mTOR), prevented DHA-mediated axon outgrowth and up-regulation of Tau and CRMP2. In addition, DHA-dependent activation of the Akt-mTOR-S6K pathway enhanced 5'-terminal oligopyrimidine tract-dependent translation of Tau and CRMP2. Therefore, our results revealed an important role for the Akt-mTOR-S6K pathway in DHA-mediated neuronal development.

Indexed as

Second Messenger SystemsAnimalsAxonsCells, CulturedDocosahexaenoic AcidsIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsNeurogenesisProto-Oncogene Proteins c-aktRatsRats, WistarRibosomal Protein S6 Kinasestau ProteinsTOR Serine-Threonine Kinasescollapsin response mediator protein-2Docosahexaenoic AcidsIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinasestau ProteinsTOR Serine-Threonine Kinasesneurite outgrowthneurodevelopmentneuronPUFAS6 kinasetranslation control

Identifiers

PMID26763232
PMCPMC4777833
OpenAlexW2236267846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.